A new set of guidelines is urging doctors to lower blood pressure targets more aggressively for patients at high risk of heart disease and stroke, a shift that could reshape how millions of Canadians are treated—but also raises questions about how widely the approach can be applied.
The updated recommendations, developed by a panel of cardiovascular experts and reviewed by public health authorities, call for tighter control in patients with diabetes, chronic kidney disease, or a history of heart attack, aiming for a systolic blood pressure of 120 mmHg or lower in these groups. For the general population, the target remains at 130 mmHg, though clinicians are encouraged to consider individual risk factors when making adjustments.
Why the change—and who is most affected?
High blood pressure, or hypertension, remains the leading risk factor for cardiovascular disease worldwide, contributing to nearly 10 million deaths annually. In Canada, roughly one in five adults lives with uncontrolled hypertension, despite available medications and lifestyle interventions. The new guidance reflects growing evidence that even modest reductions in blood pressure—especially in high-risk patients—can significantly cut the risk of heart attack, stroke, and kidney failure.
Key Findings
- Stricter targets: Patients with diabetes, kidney disease, or prior heart problems should aim for systolic blood pressure ≤120 mmHg, down from the previous target of ≤130 mmHg.
- Selective application: The general population retains a target of ≤130 mmHg, but clinicians may adjust based on individual risk profiles.
- Evidence base: Meta-analyses of large clinical trials show that tighter control in high-risk groups reduces major cardiovascular events by up to 20%.
- Implementation challenges: Experts warn that achieving these targets may require more frequent monitoring, medication adjustments, or lifestyle counseling—resources that may not be equally available across healthcare systems.
How the recommendations were developed
The guidelines were informed by a review of recent clinical trials, including data from the SPRINT study, which found that intensive blood pressure treatment in high-risk adults over 50 reduced cardiovascular events by 25%. However, the panel emphasized that the decision to lower targets was not universally supported, with some researchers arguing that the benefits in certain subgroups—such as older adults or those with frailty—remain unclear.
“For patients with multiple risk factors, getting blood pressure below 120 mmHg can make a meaningful difference in preventing strokes and heart attacks,” said one of the lead authors. “But this isn’t a one-size-fits-all approach. Clinicians need to weigh the potential benefits against the risks, such as medication side effects or falls in older adults.”
Limitations and unanswered questions
While the guidelines are based on robust trial data, several caveats remain:
- Generalizability: Most trials focused on middle-aged adults without significant comorbidities. How well the targets apply to elderly patients or those with dementia is less certain.
- Side effects: Medications needed to reach these lower targets—such as multiple diuretics or ACE inhibitors—can cause dizziness, electrolyte imbalances, or kidney strain.
- Healthcare access: Frequent blood pressure checks and medication adjustments may be difficult for patients in rural areas or those with limited primary care access.
- Cost implications: More aggressive treatment could increase drug costs, though long-term savings from prevented hospitalizations may offset this.
Public health officials noted that the guidelines do not mandate immediate changes but encourage clinicians to discuss the new targets with patients during routine visits. “This is about personalized care,” said a spokesperson. “Doctors should use these recommendations as a starting point, not a rigid rule.”
What’s next for patients and providers?
Health systems are expected to begin integrating the updated targets into electronic health records and treatment protocols over the next 12 months. Professional medical societies, including the Canadian Cardiovascular Society, are reviewing the guidelines to align their own recommendations. Meanwhile, researchers are calling for more studies on how these targets perform in real-world settings, particularly among marginalized populations.
For patients, the takeaway is clear: blood pressure management remains a critical tool for heart health, but the approach should be tailored to individual needs. Those with high-risk conditions are advised to ask their healthcare providers about whether a more intensive strategy might be appropriate.
